These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7798650)
1. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. Caron F; Pestel M; Kitzis MD; Lemeland JF; Humbert G; Gutmann L J Infect Dis; 1995 Jan; 171(1):106-12. PubMed ID: 7798650 [TBL] [Abstract][Full Text] [Related]
2. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium. Caron F; Carbon C; Gutmann L J Infect Dis; 1991 Nov; 164(5):888-93. PubMed ID: 1940467 [TBL] [Abstract][Full Text] [Related]
3. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Fantin B; Leclercq R; Arthur M; Duval J; Carbon C Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013 [TBL] [Abstract][Full Text] [Related]
4. Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium. Caron F; Lemeland JF; Humbert G; Klare I; Gutmann L J Infect Dis; 1993 Sep; 168(3):681-6. PubMed ID: 8354909 [TBL] [Abstract][Full Text] [Related]
5. Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium. Caron F; Kitzis MD; Gutmann L; Cremieux AC; Maziere B; Vallois JM; Saleh-Mghir A; Lemeland JF; Carbon C Antimicrob Agents Chemother; 1992 Dec; 36(12):2611-6. PubMed ID: 1336339 [TBL] [Abstract][Full Text] [Related]
6. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis. Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374 [TBL] [Abstract][Full Text] [Related]
8. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model. Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900 [TBL] [Abstract][Full Text] [Related]
10. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium]. Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794 [TBL] [Abstract][Full Text] [Related]
11. Importance of using relapse studies or tests for detection of antibiotic resistance before considering that a treatment for multidrug-resistant enterococcal experimental endocarditis is effective. Caron F J Infect Dis; 1997 Jan; 175(1):232-3. PubMed ID: 8985229 [No Abstract] [Full Text] [Related]
12. Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis. Lefort A; Baptista M; Fantin B; Depardieu F; Arthur M; Carbon C; Courvalin P Antimicrob Agents Chemother; 1999 Mar; 43(3):476-82. PubMed ID: 10049254 [TBL] [Abstract][Full Text] [Related]
13. Endocarditis due to high level gentamicin resistant Enterococcus faecium. Das SS; Anderson JR; Macdonald AA; Somerville KW J Infect; 1994 Mar; 28(2):185-91. PubMed ID: 8034999 [TBL] [Abstract][Full Text] [Related]
14. Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium. Lefort A; Garry L; Depardieu F; Courvalin P; Fantin B Antimicrob Agents Chemother; 2003 Nov; 47(11):3515-8. PubMed ID: 14576110 [TBL] [Abstract][Full Text] [Related]
15. Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Leclercq R; Bingen E; Su QH; Lambert-Zechovski N; Courvalin P; Duval J Antimicrob Agents Chemother; 1991 Jan; 35(1):92-8. PubMed ID: 1849711 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory. Johnson AP; Warner M; Woodford N; Speller DC; Livermore DM BMJ; 1998 Sep; 317(7159):629-30. PubMed ID: 9727989 [No Abstract] [Full Text] [Related]
17. Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis. Nicolau DP; Marangos MN; Nightingale CH; Patel KB; Cooper BW; Quintiliani R; Courvalin P; Quintiliani R Antimicrob Agents Chemother; 1996 Jan; 40(1):55-60. PubMed ID: 8787879 [TBL] [Abstract][Full Text] [Related]
18. Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium. Landman D; Quale JM; Mobarakai N; Zaman MM J Antimicrob Chemother; 1995 Jul; 36(1):253-8. PubMed ID: 8537276 [TBL] [Abstract][Full Text] [Related]
19. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations. Hayden MK; Koenig GI; Trenholme GM Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818 [TBL] [Abstract][Full Text] [Related]
20. High-level gentamicin-resistant enterococci: in vitro activity of double and triple combinations of antimicrobial drugs. Ferrara A; Dos Santos C; Cimbro M Chemotherapy; 1996; 42(1):37-46. PubMed ID: 8751265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]